As for HD patients, SARS-CoV-2-S-IFN-γ-producing CD4+ or CD8+ T-cell immunity was boosted after 3D; increases were observed not only in the percentage of responders, but also in the respective frequencies of both CD8+ and CD4+ T-cell subsets in whole blood. The gene discussed is CD4; the disease is Huntington disease.